NSRX

Conviction 81HealthcareScan · Fri, Jun 26, 2026

Bullish engulfing

NSRX$3.36+1.82%

ResistanceSupportVol 14Insider buy

Vol MA14 41.47K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Nasus Pharma LtdDrug Manufacturers - Generalwww.nasuspharma.com ↗

Price3.36

Change+1.82%

Gap-0.61%

Rel volume3.30×

Avg volume55.29K

Avg $ vol178.7K

SMA 203.14

SMA 503.03

SMA 2004.89

Price vs 50+10.81%

Price vs 200-31.33%

MA stackmixed

50/200 cross—

Supertrendup · 2.59

RSI (14)59

MACD hist0.03

MACD crossbull · 4d

Stoch %K / %D97 / 90

ADX (14)22

+DI / −DI21 / 10

RSI divergence—

MACD divergence—

ATR %+7.75%

ADR %8.47%

52w high9.15

52w low0.0000

From 52w high-63.28%

Above 52w low—

New 52w highNo

SqueezeOn · 25d

Bollinger width19.89%

%B0.85

Donchian pos64.33%

Donchian high3.68

Donchian low2.78

AVWAP (52w high)3.62

vs AVWAP high-7.28%

AVWAP (52w low)3.45

vs AVWAP low-2.50%

OBV trendUp

Chaikin MF (20)0.07

Today vs 20d3.30×

Avg vol (14d)41.47K

Avg vol (20d)55.29K

Avg $ vol (20d)178.7K

Market cap—

RS 3m (vs SPY)+7.77%

RS 6m (vs SPY)-60.60%

RS line new highNo

Trend template—

Technical rank36.4

1 week+9.45%

1 month+11.26%

3 months+40.00%

6 months-52.07%

1 year—

YTD-55.50%

P/E—

P/B10.88

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current2.24

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value28.87M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryDrug Manufacturers - General

ExchangeNYSE

Shares out11.71M

Employees7

ListedWed, Aug 13, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction81 / 100

Pattern quality—

Tech rank36.4 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Congress activity

Disclosed STOCK Act trades in NSRX

All disclosures →

No recent disclosed trades by Congress in NSRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NSRX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Teleman Dan Benjamin Chief Executive Officer · Ordinary Shares · 2026-06-17	Buy	6.55K	$20K	2026-06-17	2026-06-22
Teleman Dan Benjamin Chief Executive Officer · Ordinary Shares · 2026-04-22	Buy	2.9K	$11K	2026-04-22	2026-04-22

SEC filings

EDGAR filings in NSRX · 1 recent

EDGAR →

8-K6-KTue, Jun 9, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.